|
|||||
|
|
MK-0767, a novel dual PPARalpha/gamma agonist, displays robust antihyperglycemic and hypolipidemic activities |
|
| Authors: | Doebber Thomas W Kelly Linda J Zhou Gaochao Meurer Roger Biswas Chhabi Li Ying Wu Margaret S Ippolito Marc C Chao Yu-Sheng Wang Pei-Ran Wright Samuel D Moller David E Berger Joel P |
| Institution: | Department of Metabolic Disorders, Merck Research Laboratories, Rahway, NJ 07065, USA. |
| Abstract: | |
| Keywords: | Peroxisome proliferator-activated receptor Insulin sensitizer Hyperglycemia Dyslipidemia Type 2 diabetes |
| 本文献已被 ScienceDirect PubMed 等数据库收录！ | |